| While lower cost is a compelling reason for conducting R&D in Canada, it is just one of several. Other factors include:
Canada is home to one of the largest, most developed biotech sectors in the world
The potential for partnerships with biotech firms undertaking cutting edge R&D exists throughout Canada
Government funding and tax credits for R&D is generous
Regulations are science-based and conducive to commercialising new products
Social and demographic features make Canada an excellent place to conduct clinical trials
Market-size is enormous, since Canada as a member of the North American Free Trade Agreement (NAFTA) has increased access to both the US and Mexican marketplace |
